Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites G Engel, M Göthert, D Hoyer, E Schlicker, K Hillenbrand Naunyn-Schmiedeberg's archives of pharmacology 332, 1-7, 1986 | 983* | 1986 |
Modulation of transmitter release via presynaptic cannabinoid receptors E Schlicker, M Kathmann Trends in pharmacological sciences 22 (11), 565-572, 2001 | 813 | 2001 |
Cannabidiol is an allosteric modulator at mu-and delta-opioid receptors M Kathmann, K Flau, A Redmer, C Tränkle, E Schlicker Naunyn-Schmiedeberg's archives of pharmacology 372, 354-361, 2006 | 403 | 2006 |
Attenuation of allergic contact dermatitis through the endocannabinoid system M Karsak, E Gaffal, R Date, L Wang-Eckhardt, J Rehnelt, S Petrosino, ... science 316 (5830), 1494-1497, 2007 | 396 | 2007 |
Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors E Schlicker, K Fink, M Detzner, M Göthert Journal of Neural Transmission/General Section JNT 93, 1-10, 1993 | 390 | 1993 |
Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex E Schlicker, R Betz, M Göthert Naunyn-Schmiedeberg's archives of pharmacology 337, 588-590, 1988 | 378 | 1988 |
Modulation of neurotransmitter release via histamine H3 heteroreceptors E Schlicker, B Malinowska, M Kathmann, M Göthert Fundamental & clinical pharmacology 8 (2), 128-137, 1994 | 305 | 1994 |
Effects of cannabinoids on neurotransmission B Szabo, E Schlicker Cannabinoids, 327-365, 2005 | 302 | 2005 |
Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors E Schlicker, K Fink, M Hinterthaner, M Göthert Naunyn-Schmiedeberg's archives of pharmacology 340, 633-638, 1989 | 299 | 1989 |
Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors M Nakazi, U Bauer, T Nickel, M Kathmann, E Schlicker Naunyn-Schmiedeberg's archives of pharmacology 361, 19-24, 2000 | 258 | 2000 |
Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus E Schlicker, J Timm, J Zentner, M Göthert Naunyn-Schmiedeberg's archives of pharmacology 356, 583-589, 1997 | 204 | 1997 |
Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system E Schlicker, M Morari Peptides 21 (7), 1023-1029, 2000 | 155 | 2000 |
Involvement of presynaptic H3 receptors in the inhibitory effect of histamine on serotonin release in the rat brain cortex K Fink, E Schlicker, A Neise, M Göthert Naunyn-Schmiedeberg's archives of pharmacology 342, 513-519, 1990 | 149 | 1990 |
Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices. M Göthert, H Huth, E Schlicker Naunyn-Schmiedeberg's archives of pharmacology 317 (3), 199-203, 1981 | 140 | 1981 |
N-Methyl-d-aspartate (NMDA) receptor-mediated stimulation of noradrenaline release, but not release of other neurotransmitters, in the rat brain cortex: receptor … K Fink, M Göthert, G Molderings, E Schlicker Naunyn-Schmiedeberg's archives of pharmacology 339, 514-521, 1989 | 134 | 1989 |
Cannabinoid CB1 receptor-mediated inhibition of NMDA-and kainate-stimulated noradrenaline and dopamine release in the brain M Kathmann, U Bauer, E Schlicker, M Göthert Naunyn-Schmiedeberg's archives of pharmacology 359, 466-470, 1999 | 123 | 1999 |
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? B Malinowska, M Baranowska‐Kuczko, E Schlicker British journal of pharmacology 165 (7), 2073-2088, 2012 | 116 | 2012 |
Cannabinoid receptor-mediated inhibition of dopamine release in the retina E Schlicker, J Timm, M Göthert Naunyn-Schmiedeberg's archives of pharmacology 354, 791-795, 1996 | 114 | 1996 |
Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex E Schlicker, A Behling, G Lümmen, M Göthert Naunyn-Schmiedeberg's archives of pharmacology 345, 489-493, 1992 | 112 | 1992 |
The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype E Schlicker, K Fink, M Göthert, D Hoyer, G Molderings, I Roschke, ... Naunyn-Schmiedeberg's archives of pharmacology 340, 45-51, 1989 | 102 | 1989 |